Treace Medical ConceptsTMCI
About: Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
Employees: 477
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
736% more call options, than puts
Call options by funds: $1.21M | Put options by funds: $145K
22% more capital invested
Capital invested by funds: $228M [Q3] → $278M (+$50.2M) [Q4]
18% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 22
2% more funds holding
Funds holding: 132 [Q3] → 134 (+2) [Q4]
2% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 44
3.23% less ownership
Funds ownership: 63.11% [Q3] → 59.88% (-3.23%) [Q4]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Truist Securities Richard Newitter 55% 1-year accuracy 28 / 51 met price target | 13%upside $8 | Hold Maintained | 11 Apr 2025 |
Financial journalist opinion
Based on 151 articles about TMCI published over the past 30 days









